Managing Suicidal Thoughts, Behaviors, and Risk in Treatment-Resistant Depression
A range of therapeutic targets are likely to be relevant for reducing risk of suicide in TRD. Here's what you need to know.
Source: psychiatrictimes.com
Ther Adv News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ther Adv. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ther Adv Today - Breaking & Trending Today
Zuranolone Introduces Convenience to Postpartum Depression Care
The FDA approved zuranolone for postpartum depression in August, and the drug recently hit the market for patients this month. Experts are celebrating its delivery of care and rapid response rate.
Source: hcplive.com
Continued Cannabis Confusion
Should cannabis be regulated in the United States in a manner similar to alcohol and tobacco?
Source: psychiatrictimes.com
Investegate |NOVARTIS AG CHF0.50(REGD) Announcements | NOVARTIS AG CHF0.50(REGD): FDA approves Novartis Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma
Investegate announcements from NOVARTIS AG CHF0.50(REGD), FDA approves Novartis Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma
Source: investegate.co.uk
FDA approves Novartis Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma
68% of patients receiving Kymriah in the ELARA trial experienced complete response, with an 86% overall response rate, along with a remarkable safety profile1...
Source: prnewswire.com